The BCR–ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Jitka Malcikova, Filip Razga, Tomas Jurcek, Dana Dvorakova, Daniela Zackova, Martina Toskova, Ludmila Sebejova, Jana Smardova, Alexandra Oltova, Gabriela Vankova, Lenka Jurackova, Martin Trbusek, Sarka Pospisilova, Jiri Mayer, Zdenek Racil

Journal title: Leukemia & Lymphoma

Journal number: 10428194

Journal publisher: Taylor & Francis

Published year: 2013

Published pages: 2083-2087

DOI identifier: 10.3109/10428194.2012.762649

ISSN: 1042-8194